nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—CYP3A4—chronic kidney failure	0.272	0.546	CbGaD
Ponatinib—ABCB1—chronic kidney failure	0.227	0.454	CbGaD
Ponatinib—FGFR3—epiphyseal plate—chronic kidney failure	0.0233	0.139	CbGeAlD
Ponatinib—RET—parathyroid gland—chronic kidney failure	0.00655	0.0391	CbGeAlD
Ponatinib—PDGFRA—penis—chronic kidney failure	0.00635	0.0379	CbGeAlD
Ponatinib—LYN—blood plasma—chronic kidney failure	0.0039	0.0233	CbGeAlD
Ponatinib—BCR—blood plasma—chronic kidney failure	0.00336	0.02	CbGeAlD
Ponatinib—FLT3—blood plasma—chronic kidney failure	0.00333	0.0199	CbGeAlD
Ponatinib—TEK—artery—chronic kidney failure	0.00325	0.0194	CbGeAlD
Ponatinib—FGFR4—nephron tubule—chronic kidney failure	0.00293	0.0175	CbGeAlD
Ponatinib—SRC—artery—chronic kidney failure	0.00288	0.0172	CbGeAlD
Ponatinib—FGFR4—renal system—chronic kidney failure	0.00267	0.0159	CbGeAlD
Ponatinib—KDR—artery—chronic kidney failure	0.00265	0.0158	CbGeAlD
Ponatinib—FGFR4—kidney—chronic kidney failure	0.00258	0.0154	CbGeAlD
Ponatinib—FGFR4—cortex of kidney—chronic kidney failure	0.00251	0.015	CbGeAlD
Ponatinib—Imatinib—SLC22A2—chronic kidney failure	0.0025	0.297	CrCbGaD
Ponatinib—FGFR4—digestive system—chronic kidney failure	0.00219	0.013	CbGeAlD
Ponatinib—SRC—blood plasma—chronic kidney failure	0.00216	0.0129	CbGeAlD
Ponatinib—FGFR4—blood—chronic kidney failure	0.00208	0.0124	CbGeAlD
Ponatinib—KDR—blood plasma—chronic kidney failure	0.00199	0.0119	CbGeAlD
Ponatinib—FGFR3—renal system—chronic kidney failure	0.00182	0.0108	CbGeAlD
Ponatinib—FGFR3—urethra—chronic kidney failure	0.00179	0.0107	CbGeAlD
Ponatinib—KIT—blood plasma—chronic kidney failure	0.00176	0.0105	CbGeAlD
Ponatinib—FGFR3—kidney—chronic kidney failure	0.00176	0.0105	CbGeAlD
Ponatinib—BCR—nephron tubule—chronic kidney failure	0.00173	0.0103	CbGeAlD
Ponatinib—FGFR3—cortex of kidney—chronic kidney failure	0.00171	0.0102	CbGeAlD
Ponatinib—Nilotinib—CYP2B6—chronic kidney failure	0.00164	0.194	CrCbGaD
Ponatinib—FGFR3—gonad—chronic kidney failure	0.00163	0.00973	CbGeAlD
Ponatinib—BCR—renal system—chronic kidney failure	0.00157	0.00939	CbGeAlD
Ponatinib—BCR—urethra—chronic kidney failure	0.00155	0.00922	CbGeAlD
Ponatinib—FLT3—cardiovascular system—chronic kidney failure	0.00154	0.00921	CbGeAlD
Ponatinib—BCR—cortex of kidney—chronic kidney failure	0.00148	0.00884	CbGeAlD
Ponatinib—LYN—blood—chronic kidney failure	0.00143	0.00852	CbGeAlD
Ponatinib—BCR—gonad—chronic kidney failure	0.00141	0.00842	CbGeAlD
Ponatinib—FLT3—gonad—chronic kidney failure	0.0014	0.00836	CbGeAlD
Ponatinib—FGFR1—urethra—chronic kidney failure	0.00138	0.0082	CbGeAlD
Ponatinib—FGFR1—cortex of kidney—chronic kidney failure	0.00132	0.00786	CbGeAlD
Ponatinib—CYP3A4—urine—chronic kidney failure	0.00129	0.00771	CbGeAlD
Ponatinib—CYP2D6—urine—chronic kidney failure	0.00127	0.00758	CbGeAlD
Ponatinib—RET—renal system—chronic kidney failure	0.00125	0.00747	CbGeAlD
Ponatinib—LCK—urethra—chronic kidney failure	0.00123	0.00734	CbGeAlD
Ponatinib—BCR—blood—chronic kidney failure	0.00123	0.00734	CbGeAlD
Ponatinib—FLT3—blood—chronic kidney failure	0.00122	0.00728	CbGeAlD
Ponatinib—RET—kidney—chronic kidney failure	0.00121	0.00723	CbGeAlD
Ponatinib—FGFR2—renal system—chronic kidney failure	0.00119	0.0071	CbGeAlD
Ponatinib—FGFR2—cardiovascular system—chronic kidney failure	0.00118	0.00702	CbGeAlD
Ponatinib—FGFR2—kidney—chronic kidney failure	0.00115	0.00687	CbGeAlD
Ponatinib—TEK—renal system—chronic kidney failure	0.00114	0.00681	CbGeAlD
Ponatinib—TEK—cardiovascular system—chronic kidney failure	0.00113	0.00673	CbGeAlD
Ponatinib—TEK—urethra—chronic kidney failure	0.00112	0.00669	CbGeAlD
Ponatinib—TEK—kidney—chronic kidney failure	0.0011	0.00658	CbGeAlD
Ponatinib—TEK—cortex of kidney—chronic kidney failure	0.00108	0.00641	CbGeAlD
Ponatinib—PDGFRA—renal system—chronic kidney failure	0.00103	0.00617	CbGeAlD
Ponatinib—RET—digestive system—chronic kidney failure	0.00103	0.00613	CbGeAlD
Ponatinib—KDR—nephron tubule—chronic kidney failure	0.00103	0.00612	CbGeAlD
Ponatinib—PDGFRA—cardiovascular system—chronic kidney failure	0.00102	0.0061	CbGeAlD
Ponatinib—SRC—renal system—chronic kidney failure	0.00101	0.00605	CbGeAlD
Ponatinib—ABCB11—digestive system—chronic kidney failure	0.001	0.00599	CbGeAlD
Ponatinib—SRC—cardiovascular system—chronic kidney failure	0.001	0.00598	CbGeAlD
Ponatinib—CYP2C8—blood plasma—chronic kidney failure	0.000996	0.00594	CbGeAlD
Ponatinib—SRC—kidney—chronic kidney failure	0.000981	0.00585	CbGeAlD
Ponatinib—RET—blood—chronic kidney failure	0.000979	0.00584	CbGeAlD
Ponatinib—LCK—blood—chronic kidney failure	0.000979	0.00584	CbGeAlD
Ponatinib—FGFR2—digestive system—chronic kidney failure	0.000977	0.00583	CbGeAlD
Ponatinib—KDR—renal system—chronic kidney failure	0.000933	0.00556	CbGeAlD
Ponatinib—FGFR2—blood—chronic kidney failure	0.000931	0.00555	CbGeAlD
Ponatinib—PDGFRA—gonad—chronic kidney failure	0.000928	0.00553	CbGeAlD
Ponatinib—KDR—cardiovascular system—chronic kidney failure	0.000922	0.0055	CbGeAlD
Ponatinib—KDR—urethra—chronic kidney failure	0.000917	0.00547	CbGeAlD
Ponatinib—KIT—nephron tubule—chronic kidney failure	0.00091	0.00542	CbGeAlD
Ponatinib—SRC—gonad—chronic kidney failure	0.00091	0.00542	CbGeAlD
Ponatinib—KDR—kidney—chronic kidney failure	0.000902	0.00538	CbGeAlD
Ponatinib—Imatinib—PTGS1—chronic kidney failure	0.0009	0.107	CrCbGaD
Ponatinib—CYP3A5—blood plasma—chronic kidney failure	0.000899	0.00536	CbGeAlD
Ponatinib—TEK—blood—chronic kidney failure	0.000892	0.00532	CbGeAlD
Ponatinib—KDR—cortex of kidney—chronic kidney failure	0.000879	0.00524	CbGeAlD
Ponatinib—PDGFRA—digestive system—chronic kidney failure	0.000849	0.00506	CbGeAlD
Ponatinib—SRC—digestive system—chronic kidney failure	0.000832	0.00496	CbGeAlD
Ponatinib—KIT—renal system—chronic kidney failure	0.000827	0.00493	CbGeAlD
Ponatinib—Imatinib—CYP2C19—chronic kidney failure	0.000826	0.0978	CrCbGaD
Ponatinib—KIT—cardiovascular system—chronic kidney failure	0.000817	0.00487	CbGeAlD
Ponatinib—KIT—urethra—chronic kidney failure	0.000812	0.00484	CbGeAlD
Ponatinib—PDGFRA—blood—chronic kidney failure	0.000808	0.00482	CbGeAlD
Ponatinib—KIT—kidney—chronic kidney failure	0.0008	0.00477	CbGeAlD
Ponatinib—SRC—blood—chronic kidney failure	0.000793	0.00473	CbGeAlD
Ponatinib—ABL1—nephron tubule—chronic kidney failure	0.000792	0.00472	CbGeAlD
Ponatinib—KIT—cortex of kidney—chronic kidney failure	0.000779	0.00464	CbGeAlD
Ponatinib—KDR—digestive system—chronic kidney failure	0.000765	0.00456	CbGeAlD
Ponatinib—KIT—gonad—chronic kidney failure	0.000742	0.00442	CbGeAlD
Ponatinib—KDR—blood—chronic kidney failure	0.000729	0.00435	CbGeAlD
Ponatinib—ABL1—renal system—chronic kidney failure	0.00072	0.00429	CbGeAlD
Ponatinib—ABL1—cardiovascular system—chronic kidney failure	0.000711	0.00424	CbGeAlD
Ponatinib—ABL1—urethra—chronic kidney failure	0.000707	0.00422	CbGeAlD
Ponatinib—ABL1—kidney—chronic kidney failure	0.000696	0.00415	CbGeAlD
Ponatinib—KIT—digestive system—chronic kidney failure	0.000678	0.00404	CbGeAlD
Ponatinib—ABL1—cortex of kidney—chronic kidney failure	0.000678	0.00404	CbGeAlD
Ponatinib—CYP3A4—blood plasma—chronic kidney failure	0.000675	0.00402	CbGeAlD
Ponatinib—CYP2D6—blood plasma—chronic kidney failure	0.000664	0.00396	CbGeAlD
Ponatinib—KIT—blood—chronic kidney failure	0.000646	0.00385	CbGeAlD
Ponatinib—ABL1—gonad—chronic kidney failure	0.000646	0.00385	CbGeAlD
Ponatinib—Nilotinib—CYP3A4—chronic kidney failure	0.00063	0.0746	CrCbGaD
Ponatinib—ABL1—digestive system—chronic kidney failure	0.000591	0.00352	CbGeAlD
Ponatinib—ABL1—blood—chronic kidney failure	0.000563	0.00335	CbGeAlD
Ponatinib—Imatinib—CYP3A4—chronic kidney failure	0.000525	0.0622	CrCbGaD
Ponatinib—Nilotinib—ABCB1—chronic kidney failure	0.000524	0.0621	CrCbGaD
Ponatinib—ABCG2—nephron tubule—chronic kidney failure	0.000499	0.00298	CbGeAlD
Ponatinib—ABCB1—blood plasma—chronic kidney failure	0.000478	0.00285	CbGeAlD
Ponatinib—CYP2C8—renal system—chronic kidney failure	0.000467	0.00278	CbGeAlD
Ponatinib—CYP3A5—nephron tubule—chronic kidney failure	0.000464	0.00276	CbGeAlD
Ponatinib—Imatinib—ALB—chronic kidney failure	0.000458	0.0543	CrCbGaD
Ponatinib—CYP2C8—kidney—chronic kidney failure	0.000451	0.00269	CbGeAlD
Ponatinib—ABCG2—urethra—chronic kidney failure	0.000446	0.00266	CbGeAlD
Ponatinib—Imatinib—ABCB1—chronic kidney failure	0.000437	0.0518	CrCbGaD
Ponatinib—CYP3A5—renal system—chronic kidney failure	0.000421	0.00251	CbGeAlD
Ponatinib—CYP3A5—kidney—chronic kidney failure	0.000407	0.00243	CbGeAlD
Ponatinib—CYP3A5—cortex of kidney—chronic kidney failure	0.000397	0.00237	CbGeAlD
Ponatinib—CYP2C8—blood—chronic kidney failure	0.000365	0.00218	CbGeAlD
Ponatinib—ABCG2—blood—chronic kidney failure	0.000355	0.00212	CbGeAlD
Ponatinib—CYP3A5—digestive system—chronic kidney failure	0.000346	0.00206	CbGeAlD
Ponatinib—CYP3A5—blood—chronic kidney failure	0.000329	0.00196	CbGeAlD
Ponatinib—CYP3A4—renal system—chronic kidney failure	0.000316	0.00189	CbGeAlD
Ponatinib—CYP2D6—renal system—chronic kidney failure	0.000311	0.00186	CbGeAlD
Ponatinib—CYP3A4—kidney—chronic kidney failure	0.000306	0.00182	CbGeAlD
Ponatinib—CYP2D6—kidney—chronic kidney failure	0.000301	0.00179	CbGeAlD
Ponatinib—CYP3A4—digestive system—chronic kidney failure	0.000259	0.00155	CbGeAlD
Ponatinib—CYP2D6—digestive system—chronic kidney failure	0.000255	0.00152	CbGeAlD
Ponatinib—CYP3A4—blood—chronic kidney failure	0.000247	0.00147	CbGeAlD
Ponatinib—ABCB1—nephron tubule—chronic kidney failure	0.000246	0.00147	CbGeAlD
Ponatinib—CYP2D6—blood—chronic kidney failure	0.000243	0.00145	CbGeAlD
Ponatinib—ABCB1—renal system—chronic kidney failure	0.000224	0.00133	CbGeAlD
Ponatinib—ABCB1—cardiovascular system—chronic kidney failure	0.000221	0.00132	CbGeAlD
Ponatinib—ABCB1—urethra—chronic kidney failure	0.00022	0.00131	CbGeAlD
Ponatinib—ABCB1—kidney—chronic kidney failure	0.000216	0.00129	CbGeAlD
Ponatinib—ABCB1—cortex of kidney—chronic kidney failure	0.000211	0.00126	CbGeAlD
Ponatinib—ABCB1—gonad—chronic kidney failure	0.000201	0.0012	CbGeAlD
Ponatinib—ABCB1—digestive system—chronic kidney failure	0.000184	0.00109	CbGeAlD
Ponatinib—ABCB1—blood—chronic kidney failure	0.000175	0.00104	CbGeAlD
Ponatinib—ABCB11—Metabolism—PTGS2—chronic kidney failure	6.93e-06	2.13e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—FASN—chronic kidney failure	6.93e-06	2.13e-05	CbGpPWpGaD
Ponatinib—SRC—Hemostasis—KRAS—chronic kidney failure	6.92e-06	2.13e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL1B—chronic kidney failure	6.91e-06	2.13e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—LPL—chronic kidney failure	6.89e-06	2.12e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—POMC—chronic kidney failure	6.88e-06	2.12e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—POMC—chronic kidney failure	6.86e-06	2.11e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CPT1A—chronic kidney failure	6.84e-06	2.1e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—LCAT—chronic kidney failure	6.8e-06	2.09e-05	CbGpPWpGaD
Ponatinib—LCK—Adaptive Immune System—KRAS—chronic kidney failure	6.75e-06	2.08e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—VEGFA—chronic kidney failure	6.74e-06	2.07e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—SERPINE1—chronic kidney failure	6.74e-06	2.07e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—CCL2—chronic kidney failure	6.73e-06	2.07e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—CCL2—chronic kidney failure	6.71e-06	2.07e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—LIPC—chronic kidney failure	6.66e-06	2.05e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CYP2C19—chronic kidney failure	6.66e-06	2.05e-05	CbGpPWpGaD
Ponatinib—FGFR3—Disease—IL6—chronic kidney failure	6.66e-06	2.05e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—F2—chronic kidney failure	6.64e-06	2.04e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—SERPINE1—chronic kidney failure	6.62e-06	2.04e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IGF1—chronic kidney failure	6.62e-06	2.04e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—AVP—chronic kidney failure	6.61e-06	2.03e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IGF1—chronic kidney failure	6.6e-06	2.03e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—SCARB1—chronic kidney failure	6.53e-06	2.01e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NGF—chronic kidney failure	6.52e-06	2.01e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—IRS1—chronic kidney failure	6.51e-06	2e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—NFKB1—chronic kidney failure	6.48e-06	1.99e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—NFKB1—chronic kidney failure	6.47e-06	1.99e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—SERPINE1—chronic kidney failure	6.47e-06	1.99e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTGS1—chronic kidney failure	6.47e-06	1.99e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—NFKB1—chronic kidney failure	6.45e-06	1.98e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—NOS3—chronic kidney failure	6.43e-06	1.98e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CYP3A4—chronic kidney failure	6.42e-06	1.98e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	6.39e-06	1.97e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CCR5—chronic kidney failure	6.35e-06	1.95e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—SREBF1—chronic kidney failure	6.34e-06	1.95e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—NOS3—chronic kidney failure	6.32e-06	1.95e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ABCA1—chronic kidney failure	6.31e-06	1.94e-05	CbGpPWpGaD
Ponatinib—FGFR4—Signaling Pathways—IL6—chronic kidney failure	6.3e-06	1.94e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—RELA—chronic kidney failure	6.3e-06	1.94e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—EDN1—chronic kidney failure	6.28e-06	1.93e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IRS1—chronic kidney failure	6.28e-06	1.93e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—SERPINE1—chronic kidney failure	6.28e-06	1.93e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—SERPINE1—chronic kidney failure	6.27e-06	1.93e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—DDC—chronic kidney failure	6.24e-06	1.92e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCL5—chronic kidney failure	6.24e-06	1.92e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—KRAS—chronic kidney failure	6.23e-06	1.92e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—TGFB1—chronic kidney failure	6.19e-06	1.9e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—NOS3—chronic kidney failure	6.18e-06	1.9e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—HMGCR—chronic kidney failure	6.17e-06	1.9e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CAT—chronic kidney failure	6.17e-06	1.9e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—SCARB1—chronic kidney failure	6.15e-06	1.89e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—LPL—chronic kidney failure	6.1e-06	1.88e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—KRAS—chronic kidney failure	6.1e-06	1.88e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTGS1—chronic kidney failure	6.09e-06	1.88e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—TGFB1—chronic kidney failure	6.08e-06	1.87e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PRKD1—chronic kidney failure	6.06e-06	1.87e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PRKAG2—chronic kidney failure	6.06e-06	1.87e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYP2B6—chronic kidney failure	6.06e-06	1.87e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—RELA—chronic kidney failure	6.06e-06	1.86e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—POMC—chronic kidney failure	6.05e-06	1.86e-05	CbGpPWpGaD
Ponatinib—ABCB1—Transmembrane transport of small molecules—ALB—chronic kidney failure	6.05e-06	1.86e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—FASN—chronic kidney failure	6.04e-06	1.86e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ABCB1—chronic kidney failure	6e-06	1.85e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—NOS3—chronic kidney failure	6e-06	1.85e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—KRAS—chronic kidney failure	5.99e-06	1.84e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—NOS3—chronic kidney failure	5.98e-06	1.84e-05	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—KRAS—chronic kidney failure	5.98e-06	1.84e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—SREBF1—chronic kidney failure	5.98e-06	1.84e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—TGFB1—chronic kidney failure	5.97e-06	1.84e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—RELA—chronic kidney failure	5.95e-06	1.83e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—CCL2—chronic kidney failure	5.92e-06	1.82e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—VEGFA—chronic kidney failure	5.87e-06	1.81e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IGF1—chronic kidney failure	5.82e-06	1.79e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—HMGCR—chronic kidney failure	5.81e-06	1.79e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NGF—chronic kidney failure	5.77e-06	1.78e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—POMC—chronic kidney failure	5.75e-06	1.77e-05	CbGpPWpGaD
Ponatinib—SRC—Developmental Biology—IL6—chronic kidney failure	5.74e-06	1.77e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—KRAS—chronic kidney failure	5.73e-06	1.76e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—SERPINE1—chronic kidney failure	5.73e-06	1.76e-05	CbGpPWpGaD
Ponatinib—LCK—Innate Immune System—IL6—chronic kidney failure	5.72e-06	1.76e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—LPL—chronic kidney failure	5.72e-06	1.76e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL1B—chronic kidney failure	5.69e-06	1.75e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—FASN—chronic kidney failure	5.69e-06	1.75e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—KRAS—chronic kidney failure	5.68e-06	1.75e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—SREBF2—chronic kidney failure	5.68e-06	1.75e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—KRAS—chronic kidney failure	5.67e-06	1.74e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—TGFB1—chronic kidney failure	5.66e-06	1.74e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—PTGS2—chronic kidney failure	5.65e-06	1.74e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—TGFB1—chronic kidney failure	5.65e-06	1.74e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—RELA—chronic kidney failure	5.65e-06	1.74e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—RELA—chronic kidney failure	5.63e-06	1.73e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—KRAS—chronic kidney failure	5.63e-06	1.73e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCR5—chronic kidney failure	5.62e-06	1.73e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CYP3A4—chronic kidney failure	5.59e-06	1.72e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—RELA—chronic kidney failure	5.57e-06	1.72e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—KRAS—chronic kidney failure	5.53e-06	1.7e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—SERPINE1—chronic kidney failure	5.53e-06	1.7e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—CYP1A1—chronic kidney failure	5.52e-06	1.7e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ABCA1—chronic kidney failure	5.5e-06	1.69e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GCKR—chronic kidney failure	5.48e-06	1.69e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ABCC3—chronic kidney failure	5.48e-06	1.69e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—NOS3—chronic kidney failure	5.47e-06	1.68e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—F2—chronic kidney failure	5.44e-06	1.68e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—TGFB1—chronic kidney failure	5.39e-06	1.66e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—LPIN1—chronic kidney failure	5.37e-06	1.65e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CAT—chronic kidney failure	5.34e-06	1.64e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—NFKB1—chronic kidney failure	5.31e-06	1.63e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—NOS3—chronic kidney failure	5.28e-06	1.62e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CYP3A4—chronic kidney failure	5.27e-06	1.62e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—LRP2—chronic kidney failure	5.26e-06	1.62e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYP2C18—chronic kidney failure	5.26e-06	1.62e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—KRAS—chronic kidney failure	5.25e-06	1.61e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—ALB—chronic kidney failure	5.24e-06	1.61e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—KRAS—chronic kidney failure	5.23e-06	1.61e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ABCB1—chronic kidney failure	5.2e-06	1.6e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ABCA1—chronic kidney failure	5.18e-06	1.59e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IRS1—chronic kidney failure	5.15e-06	1.59e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—MTHFR—chronic kidney failure	5.15e-06	1.58e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—NFKB1—chronic kidney failure	5.11e-06	1.57e-05	CbGpPWpGaD
Ponatinib—SRC—Innate Immune System—IL6—chronic kidney failure	5.07e-06	1.56e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PPARA—chronic kidney failure	5.05e-06	1.55e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL1B—chronic kidney failure	5.04e-06	1.55e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—NFKB1—chronic kidney failure	5.02e-06	1.54e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—NOS3—chronic kidney failure	5.01e-06	1.54e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—PTGS2—chronic kidney failure	5e-06	1.54e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—KRAS—chronic kidney failure	5e-06	1.54e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—KRAS—chronic kidney failure	4.99e-06	1.54e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—KRAS—chronic kidney failure	4.98e-06	1.53e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—RELA—chronic kidney failure	4.97e-06	1.53e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—POMC—chronic kidney failure	4.96e-06	1.53e-05	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—IL6—chronic kidney failure	4.96e-06	1.53e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—LPL—chronic kidney failure	4.95e-06	1.52e-05	CbGpPWpGaD
Ponatinib—KIT—Immune System—IL6—chronic kidney failure	4.87e-06	1.5e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—CCL2—chronic kidney failure	4.85e-06	1.49e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—F2—chronic kidney failure	4.82e-06	1.48e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CYP1A1—chronic kidney failure	4.78e-06	1.47e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IGF1—chronic kidney failure	4.77e-06	1.47e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—NFKB1—chronic kidney failure	4.76e-06	1.47e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—NFKB1—chronic kidney failure	4.75e-06	1.46e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—NFKB1—chronic kidney failure	4.7e-06	1.45e-05	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—IL6—chronic kidney failure	4.66e-06	1.43e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CAT—chronic kidney failure	4.65e-06	1.43e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—VEGFA—chronic kidney failure	4.64e-06	1.43e-05	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—IL6—chronic kidney failure	4.62e-06	1.42e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL6—chronic kidney failure	4.61e-06	1.42e-05	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PTGS2—chronic kidney failure	4.58e-06	1.41e-05	CbGpPWpGaD
Ponatinib—FGFR2—Disease—IL6—chronic kidney failure	4.58e-06	1.41e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IRS1—chronic kidney failure	4.56e-06	1.4e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—VEGFA—chronic kidney failure	4.55e-06	1.4e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—SERPINE1—chronic kidney failure	4.53e-06	1.39e-05	CbGpPWpGaD
Ponatinib—KIT—Disease—IL6—chronic kidney failure	4.5e-06	1.38e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CPT1A—chronic kidney failure	4.47e-06	1.38e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—MTHFR—chronic kidney failure	4.46e-06	1.37e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—POMC—chronic kidney failure	4.39e-06	1.35e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CAT—chronic kidney failure	4.39e-06	1.35e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PPARA—chronic kidney failure	4.37e-06	1.35e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYP2C19—chronic kidney failure	4.36e-06	1.34e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—LIPC—chronic kidney failure	4.36e-06	1.34e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NOS3—chronic kidney failure	4.32e-06	1.33e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—VEGFA—chronic kidney failure	4.32e-06	1.33e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—LPL—chronic kidney failure	4.31e-06	1.33e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—VEGFA—chronic kidney failure	4.31e-06	1.33e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCL2—chronic kidney failure	4.3e-06	1.32e-05	CbGpPWpGaD
Ponatinib—FGFR1—Disease—IL6—chronic kidney failure	4.27e-06	1.31e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ABCB1—chronic kidney failure	4.27e-06	1.31e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—IL6—chronic kidney failure	4.26e-06	1.31e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TGFB1—chronic kidney failure	4.25e-06	1.31e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IGF1—chronic kidney failure	4.22e-06	1.3e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—NFKB1—chronic kidney failure	4.19e-06	1.29e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TGFB1—chronic kidney failure	4.18e-06	1.29e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CYP1A1—chronic kidney failure	4.17e-06	1.28e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—POMC—chronic kidney failure	4.12e-06	1.27e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—KRAS—chronic kidney failure	4.1e-06	1.26e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—TGFB1—chronic kidney failure	4.08e-06	1.26e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—RELA—chronic kidney failure	4.07e-06	1.25e-05	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL6—chronic kidney failure	4.07e-06	1.25e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—LPL—chronic kidney failure	4.07e-06	1.25e-05	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL6—chronic kidney failure	4.06e-06	1.25e-05	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL6—chronic kidney failure	4.05e-06	1.25e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—SCARB1—chronic kidney failure	4.02e-06	1.24e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—SERPINE1—chronic kidney failure	4.01e-06	1.23e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGS1—chronic kidney failure	3.98e-06	1.23e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TGFB1—chronic kidney failure	3.97e-06	1.22e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TGFB1—chronic kidney failure	3.96e-06	1.22e-05	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—KRAS—chronic kidney failure	3.94e-06	1.21e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CYP1A1—chronic kidney failure	3.93e-06	1.21e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—SREBF1—chronic kidney failure	3.91e-06	1.2e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—MTHFR—chronic kidney failure	3.88e-06	1.2e-05	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—KRAS—chronic kidney failure	3.87e-06	1.19e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NOS3—chronic kidney failure	3.83e-06	1.18e-05	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PPARA—chronic kidney failure	3.81e-06	1.17e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—VEGFA—chronic kidney failure	3.8e-06	1.17e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—HMGCR—chronic kidney failure	3.8e-06	1.17e-05	CbGpPWpGaD
Ponatinib—LCK—Disease—KRAS—chronic kidney failure	3.78e-06	1.16e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ALB—chronic kidney failure	3.75e-06	1.16e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—FASN—chronic kidney failure	3.72e-06	1.14e-05	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—KRAS—chronic kidney failure	3.67e-06	1.13e-05	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—KRAS—chronic kidney failure	3.66e-06	1.13e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—MTHFR—chronic kidney failure	3.66e-06	1.13e-05	CbGpPWpGaD
Ponatinib—SRC—Immune System—KRAS—chronic kidney failure	3.63e-06	1.12e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—TGFB1—chronic kidney failure	3.62e-06	1.11e-05	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—RELA—chronic kidney failure	3.6e-06	1.11e-05	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PPARA—chronic kidney failure	3.59e-06	1.11e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—NOS3—chronic kidney failure	3.59e-06	1.11e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—POMC—chronic kidney failure	3.57e-06	1.1e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TGFB1—chronic kidney failure	3.49e-06	1.07e-05	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NFKB1—chronic kidney failure	3.43e-06	1.06e-05	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ABCA1—chronic kidney failure	3.39e-06	1.04e-05	CbGpPWpGaD
Ponatinib—SRC—Disease—KRAS—chronic kidney failure	3.35e-06	1.03e-05	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL6—chronic kidney failure	3.33e-06	1.03e-05	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PTGS2—chronic kidney failure	3.28e-06	1.01e-05	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ALB—chronic kidney failure	3.25e-06	1e-05	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—KRAS—chronic kidney failure	3.23e-06	9.95e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL6—chronic kidney failure	3.21e-06	9.87e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL6—chronic kidney failure	3.15e-06	9.69e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—VEGFA—chronic kidney failure	3.12e-06	9.59e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—NOS3—chronic kidney failure	3.11e-06	9.57e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—POMC—chronic kidney failure	3.11e-06	9.56e-06	CbGpPWpGaD
Ponatinib—LCK—Disease—IL6—chronic kidney failure	3.08e-06	9.47e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NFKB1—chronic kidney failure	3.04e-06	9.35e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL6—chronic kidney failure	2.99e-06	9.2e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL6—chronic kidney failure	2.98e-06	9.17e-06	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL6—chronic kidney failure	2.95e-06	9.08e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—POMC—chronic kidney failure	2.93e-06	9.01e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CAT—chronic kidney failure	2.87e-06	8.83e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TGFB1—chronic kidney failure	2.86e-06	8.8e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTGS2—chronic kidney failure	2.84e-06	8.75e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ALB—chronic kidney failure	2.83e-06	8.72e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ABCB1—chronic kidney failure	2.79e-06	8.59e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—VEGFA—chronic kidney failure	2.76e-06	8.49e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—IL6—chronic kidney failure	2.72e-06	8.39e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—NOS3—chronic kidney failure	2.71e-06	8.34e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ALB—chronic kidney failure	2.67e-06	8.21e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—LPL—chronic kidney failure	2.66e-06	8.18e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—KRAS—chronic kidney failure	2.65e-06	8.15e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL6—chronic kidney failure	2.63e-06	8.09e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYP1A1—chronic kidney failure	2.57e-06	7.9e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—NOS3—chronic kidney failure	2.55e-06	7.86e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TGFB1—chronic kidney failure	2.53e-06	7.79e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTGS2—chronic kidney failure	2.48e-06	7.63e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—MTHFR—chronic kidney failure	2.39e-06	7.37e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PPARA—chronic kidney failure	2.35e-06	7.23e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—KRAS—chronic kidney failure	2.35e-06	7.22e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTGS2—chronic kidney failure	2.33e-06	7.19e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL6—chronic kidney failure	2.16e-06	6.63e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—POMC—chronic kidney failure	1.91e-06	5.89e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL6—chronic kidney failure	1.91e-06	5.87e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ALB—chronic kidney failure	1.74e-06	5.37e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—NOS3—chronic kidney failure	1.67e-06	5.14e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGS2—chronic kidney failure	1.53e-06	4.7e-06	CbGpPWpGaD
